Arca
Skip to content

IL6R: Interleukin-6 receptor subunit alpha

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

Part of the receptor for interleukin 6.

  • Drugs that act on it: 4
  • With a US drug page: 1
  • Type: Protein

Drugs That Act on It

Approved and clinical-stage drugs ChEMBL records for this target; those with a US drug page link to it
SarilumabApprovedInterleukin-6 receptor alpha subunit antagonistAntagonistBoxed warning
Levilimab—Interleukin-6 receptor alpha subunit inhibitorInhibitor—
Tocilizumab—Interleukin-6 receptor alpha subunit inhibitorInhibitorBoxed warning
Vobarilizumab—Interleukin-6 receptor alpha subunit inhibitorInhibitor—

Diseases Most Associated With It

Open Targets association score, 0 to 1; all associations
Atopic eczema
0.70
Coronary artery disorder
0.60
Temporal arteritis
0.58
Asthma
0.58
Hyper-IgE recurrent infection syndrome 5, autosomal recessive
0.57
Abdominal aortic aneurysm
0.55
Immune system disorder
0.53

Genes and Related Targets

Complexes and families that share a gene with this target
Genes
IL6R

Drugs and mechanisms are from ChEMBL CHEMBL2364155 (CC BY-SA 3.0). Gene name, function (UniProt P08887, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.